[go: up one dir, main page]

HK1220365B - 用於靶向癌症干细胞的依托泊苷前体药物 - Google Patents

用於靶向癌症干细胞的依托泊苷前体药物 Download PDF

Info

Publication number
HK1220365B
HK1220365B HK16108405.4A HK16108405A HK1220365B HK 1220365 B HK1220365 B HK 1220365B HK 16108405 A HK16108405 A HK 16108405A HK 1220365 B HK1220365 B HK 1220365B
Authority
HK
Hong Kong
Prior art keywords
cancer
compound
tumor
use according
stem cells
Prior art date
Application number
HK16108405.4A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1220365A1 (zh
Inventor
Nalan Utku
Steven R. Gullans
Original Assignee
Cellact Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB1304417.7A external-priority patent/GB2513299A/en
Application filed by Cellact Pharma Gmbh filed Critical Cellact Pharma Gmbh
Publication of HK1220365A1 publication Critical patent/HK1220365A1/zh
Publication of HK1220365B publication Critical patent/HK1220365B/zh

Links

HK16108405.4A 2013-03-12 2014-03-12 用於靶向癌症干细胞的依托泊苷前体药物 HK1220365B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1304417.7 2013-03-12
GB1304417.7A GB2513299A (en) 2013-03-12 2013-03-12 Compounds for targeting cancer stem cells
PCT/EP2014/054785 WO2014140072A1 (en) 2013-03-12 2014-03-12 Etoposide and prodrugs thereof for use in targeting cancer stem cells

Publications (2)

Publication Number Publication Date
HK1220365A1 HK1220365A1 (zh) 2017-05-05
HK1220365B true HK1220365B (zh) 2022-01-14

Family

ID=

Similar Documents

Publication Publication Date Title
EP2968379B1 (en) Etoposide prodrugs for use in targeting cancer stem cells
US20130280210A1 (en) Methods for regulating cell mitosis by inhibiting serine/threonine phosphatase
JP6666494B2 (ja) がんの処置のための医薬の組合せ
EP2309853A1 (en) Methods for regulating cell mitosis by inhibiting serine/threonine phosphatase
JP2019511553A (ja) 静止細胞標的化および有糸分裂の阻害剤を用いた新生物の処置のための組み合わせ
JP2019048850A (ja) メトホルミン及びジヒドロケルセチンを含む組み合わせ医薬、及びがんの治療のための使用
CA3100211A1 (en) Formulations and methods for the prevention and treatment of tumor metastasis and tumorigenesis
JP2018511643A (ja) 癌を治療するための方法
US20240355686A1 (en) Clinical Methods and Pharmaceutical Compositions Employing AMPA Receptor Antagonists to Treat Glioblastoma and Other Cancers
CN107683137A (zh) 用于使用stat3途径抑制剂和激酶抑制剂治疗癌症的方法
KR101825637B1 (ko) 암 예방 또는 치료용 약학적 조성물 및 이의 용도
US10485769B2 (en) Cholesteryl ester transfer protein (CETP) inhibition in the treatment of cancer
US20100226919A1 (en) Antitumoral Treatments
US20130150386A1 (en) Methods for the treatment of lung cancer
JP7361779B2 (ja) がんに治療的処置をするためのｃ－１９ステロイドの組み合わせ
HK1220365B (zh) 用於靶向癌症干细胞的依托泊苷前体药物
KR101824205B1 (ko) 암 예방 또는 치료용 약학적 조성물 및 이의 용도
US12472227B2 (en) Pharmaceutical compositions and use thereof for relieving resistance due to cancer chemotherapy and enhancing effect of cancer chemotherapy
KR101828997B1 (ko) 암 예방 또는 치료용 약학적 조성물 및 이의 용도
KR101824197B1 (ko) 암 예방 또는 치료용 약학적 조성물 및 이의 용도
CA3145507A1 (en) Clinical methods and pharmaceutical compositions employing ampa receptor antagonists to treat glioblastoma and other cancers
EP3854411A1 (en) Pharmaceutical compositions and use thereof for relieving resistance due to cancer chemotherapy and enhancing effect of cancer chemotherapy
Korsch Investigation of Alternative Treatment Options for Pancreatic Cancer
HK40029376B (zh) 用於抑制化疗引起副作用的药物治疗、筛选技术和试剂盒
KR20250019775A (ko) 암 치료를 위한 조성물 및 방법